Stages I–II (n=102) | Univariate | Multivariate | ||||
---|---|---|---|---|---|---|
HR | 95% CI | p-value | HR | 95% CI | p-value | |
High Wip1 | 0.58 | 0.13–2.51 | 0.46 | - | - | - |
Positive p53 | 2.48 | 0.92–6.65 | 0.071 | - | - | - |
High phospho-p53 | 2.43 | 0.32–18.3 | 0.39 | - | - | - |
High nuclear phospho-p38 | 1.00 | 0.39–2.51 | 0.99 | - | - | - |
High cytoplasmic phospho-p38 | 1.56 | 0.36–6.81 | 0.56 | - | - | - |
Age ≥ 60 | 1.70 | 0.46–3.60 | 0.64 | - | - | - |
Positive peritoneal cytology | 8.23 | 2.93–23.2 | 0.00065 | 9.25 | 3.19–26.9 | 0.00043 |
Residual tumor present | 9.62 | 1.21–76.3 | 0.032 | 21.7 | 2.28–205.4 | 0.0074 |
Endometriosis present | 1.07 | 0.41–2.76 | 0.89 | - | - | - |
Lymphadenectmy undone | 2.69 | 0.96–7.56 | 0.060 | - | - | - |
Adjuvant chemotherapy performed | 1.07 | 0.14–8.10 | 0.94 | - | - | - |
Pure histology | 0.29 | 0.038–2.18 | 0.23 | - | - | - |